Cargando…
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
INTRODUCTION: Autosomal dominant polycystic kidney disease is the most common hereditary kidney disease. TKV is a promising imaging biomarker for tracking and predicting the natural history of autosomal dominant polycystic kidney disease. The prognostic value of TKV was evaluated, in combination wit...
Autores principales: | Perrone, Ronald D., Mouksassi, Mohamad-Samer, Romero, Klaus, Czerwiec, Frank S., Chapman, Arlene B., Gitomer, Berenice Y., Torres, Vicente E., Miskulin, Dana C., Broadbent, Steve, Marier, Jean F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678856/ https://www.ncbi.nlm.nih.gov/pubmed/29142971 http://dx.doi.org/10.1016/j.ekir.2017.01.003 |
Ejemplares similares
-
A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease
por: Perrone, Ronald D., et al.
Publicado: (2017) -
Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021) -
Developments in the management of autosomal dominant polycystic
kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008) -
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients
por: Hanudel, Mark R., et al.
Publicado: (2019) -
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease
por: Grantham, Jared J., et al.
Publicado: (2017)